-
Tumor Profiler Project - OV scRNA data
Dataset
EGAD50000001290
-
Tumor Profiler Project - OV scDNA data
Dataset
EGAD50000001291
-
De novo detection of somatic variants
Dataset
EGAD50000001292
-
Tumor Profiler Project - OV scRNA data additional samples
Dataset
EGAD50000001293
-
Tumor Profiler Project - OV scDNA data additional samples
Dataset
EGAD50000001294
-
Proteogenomic Analysis of CALGB40601 (ALLIANCE) a Neoadjuvant Phase III HER2-Positive Breast Cancer Trial
Study
phs003576
-
DNA Methylation in Prostate Tumor and Paired Benign Tissue for African and European Ancestry Men
Study
phs003516
-
Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial
Study
phs003922
-
Array-based methylation analysis of SDHB-deficient pheochromocytoma and paraganglioma
Study
EGAS00001007844
-
Multi-omic analysis of SDHB-related PCPG
Study
EGAS50000000346
-
Rapid brain tumor classification from sparse epigenomic data
Study
EGAS50000000559
-
Study of biomarkers implicated in radio-immunotherapy response in metastatic cancer
Study
EGAS50000000681
-
Gene expression adaptation of metastases to their host tissue
Study
EGAS50000000817
-
Timing and trajectory of BCR-ABL1 driven chronic myeloid leukaemia
Dataset
EGAD00001015473
-
MOSAIC Window Glioblastoma Data
Dataset
EGAD50000001352
-
The dataset for Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer
Dataset
EGAD50000001353
-
The data access committee for Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer
Dac
EGAC50000000588
-
APOBEC Breast Cancer Whole Genome
Dataset
EGAD50000001275
-
Total RNAseq data from 8 patients with muscle invasive bladder cancer
Dataset
EGAD50000001380
-
Single cell RNAseq and TCRseq data from tumor and blood samples from 4 patients with muscle invasive bladder cancer
Dataset
EGAD50000001381
-
Bulk TCRseq data from 149 patients with bladder cancer
Dataset
EGAD50000001382
-
Subclonal variation in patients with pediatric T-lymphoblastic leukemia (T-ALL)
Study
EGAS50000000794
-
PanCancer_Phosphoproteomics2024
Dataset
EGAD00010002730
-
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Study
phs003294
-
Durvalumab Plus Tremelimumab Alone or in Combination with Low-Dose or Hypofractionated Radiotherapy in Metastatic Non-Small-Cell Lung Cancer Refractory to Previous PD(L)-1 Therapy: an Open-Label, Multicentre, Randomised, Phase 2 Trial
Study
phs003295